secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alkermes plc. (ALKS)
CIK:        0001520262
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001193125-26-068927
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alkermes CEO Richard Pops to retire July 31, 2026; COO Blair Jackson named successor
--------------------------------------------------------------------------------

- Richard Pops retires as CEO effective July 31, 2026, after 35-year tenure; will remain Chairman and Senior Advisor through Dec 31, 2026.
- Blair Jackson, current EVP/COO, appointed CEO effective Aug 1, 2026; Jackson has over 25 years experience at Alkermes.
- Pops receives $75k/month advisory retainer, pro-rated FY2026 bonus at target, $2.69M RSU grant vesting Dec 31, 2026, and $40k Chairman retainer.
- Outstanding equity awards continue vesting post-retirement; post-termination exercise periods extended up to 21 months.
- Company cites ~$1.5B annual revenue, ~2,000 employees, and alixorexton's Breakthrough Therapy designation for narcolepsy type 1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520262/000119312526068927/0001193125-26-068927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520262/000119312526068927/alks-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-068927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer